304 related articles for article (PubMed ID: 3297617)
1. Ofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Monk JP; Campoli-Richards DM
Drugs; 1987 Apr; 33(4):346-91. PubMed ID: 3297617
[TBL] [Abstract][Full Text] [Related]
2. Ofloxacin in urinary tract infections.
Kromann-Andersen B; Krøyer Nielsen K
Scand J Infect Dis Suppl; 1990; 68():35-40. PubMed ID: 2218420
[TBL] [Abstract][Full Text] [Related]
3. Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Campoli-Richards DM; Monk JP; Price A; Benfield P; Todd PA; Ward A
Drugs; 1988 Apr; 35(4):373-447. PubMed ID: 3292209
[TBL] [Abstract][Full Text] [Related]
4. [The history of the development and changes of quinolone antibacterial agents].
Takahashi H; Hayakawa I; Akimoto T
Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the antibacterial in vitro and in vivo activity of ofloxacin (HOE 280 DL 8280) and nalidixic acid analogues.
Seibert G; Limbert M; Klesel N
Eur J Clin Microbiol; 1983 Dec; 2(6):548-53. PubMed ID: 6230226
[TBL] [Abstract][Full Text] [Related]
6. Review of the 4-quinolones.
Eggleston M; Park SY
Infect Control; 1987 Mar; 8(3):119-25. PubMed ID: 3553053
[TBL] [Abstract][Full Text] [Related]
7. Ofloxacin. A reappraisal of its antimicrobial activity, pharmacology and therapeutic use.
Todd PA; Faulds D
Drugs; 1991 Nov; 42(5):825-76. PubMed ID: 1723377
[TBL] [Abstract][Full Text] [Related]
8. Antibacterial activity of ofloxacin and its mode of action.
Sato K; Inoue Y; Fujii T; Aoyama H; Mitsuhashi S
Infection; 1986; 14 Suppl 4():S226-30. PubMed ID: 3028966
[TBL] [Abstract][Full Text] [Related]
9. Ofloxacin: in vitro and in vivo activity.
Guerra L; Caro B; Erani E; Xerri L
Chemioterapia; 1987 Feb; 6(1):23-31. PubMed ID: 3470154
[TBL] [Abstract][Full Text] [Related]
10. Levofloxacin: a review of its use in the treatment of bacterial infections in the United States.
Croom KF; Goa KL
Drugs; 2003; 63(24):2769-802. PubMed ID: 14664657
[TBL] [Abstract][Full Text] [Related]
11. [In vitro antibacterial activity and pharmacokinetics of ofloxacin in chronic respiratory tract infections].
Sugimoto Y; Matsumoto Y; Hitsuda Y; Yamamoto Y; Ishitobi K; Sasaki T
Jpn J Antibiot; 1987 Feb; 40(2):325-30. PubMed ID: 3474429
[TBL] [Abstract][Full Text] [Related]
12. Ofloxacin: antibacterial activity, induction of resistance and killing curves.
Husson MO; Izard D; Bryskier A; Leclerc H
Chemioterapia; 1985 Aug; 4(4):278-83. PubMed ID: 3863716
[TBL] [Abstract][Full Text] [Related]
13. Ofloxacin: its pharmacology, pharmacokinetics, and potential for clinical application.
Drew RH; Gallis HA
Pharmacotherapy; 1988; 8(1):35-46. PubMed ID: 3287354
[TBL] [Abstract][Full Text] [Related]
14. [Anti-bacterial effect of ofloxacin--in vitro and in vivo results].
Altay G; Tulunay C
Mikrobiyol Bul; 1985 Oct; 19(4):183-9. PubMed ID: 3868736
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo activity of DL-8280, a new oxazine derivative.
Sato K; Matsuura Y; Inoue M; Une T; Osada Y; Ogawa H; Mitsuhashi S
Antimicrob Agents Chemother; 1982 Oct; 22(4):548-53. PubMed ID: 6960805
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity and concentrations in serum, urine, prostatic secretion and adenoma tissue of ofloxacin in urological patients.
Naber KG; Adam D; Kees F
Drugs; 1987; 34 Suppl 1():44-50. PubMed ID: 3481328
[TBL] [Abstract][Full Text] [Related]
17. International experiences with ofloxacin, a new quinolone.
Mitsuhashi S
Infection; 1986; 14 Suppl 4():S223-5. PubMed ID: 3028965
[TBL] [Abstract][Full Text] [Related]
18. Aztreonam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Brogden RN; Heel RC
Drugs; 1986 Feb; 31(2):96-130. PubMed ID: 3512234
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility of Legionella pneumophila to ofloxacin in vitro and in experimental Legionella pneumonia in guinea pigs.
Saito A; Sawatari K; Fukuda Y; Nagasawa M; Koga H; Tomonaga A; Nakazato H; Fujita K; Shigeno Y; Suzuyama Y
Antimicrob Agents Chemother; 1985 Jul; 28(1):15-20. PubMed ID: 3862361
[TBL] [Abstract][Full Text] [Related]
20. Quinolones in the treatment of serious infections.
Webster A; Gaya H
Rev Infect Dis; 1988; 10 Suppl 1():S225-33. PubMed ID: 3279496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
